These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 4627387)
1. [Method of labelled inhibitors and its applications]. Przegl Lek; 1972; 29(7):663-9. PubMed ID: 4627387 [No Abstract] [Full Text] [Related]
2. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys. Henderson ES; Adamson RH; Denham C; Oliverio VT Cancer Res; 1965 Aug; 25(7):1008-17. PubMed ID: 4954195 [No Abstract] [Full Text] [Related]
3. Studies on folic reductase. 3. The level of enzyme activity and response to methotrexate of transplantable mouse tumors. Roberts D; Wodinsky I; Hall TC Cancer Res; 1965 Dec; 25(11):1899-903. PubMed ID: 5856519 [No Abstract] [Full Text] [Related]
4. [Site of action of the coronary medication, carbochromen]. Alfes H; Schraven E; Möllmann H; Ostrowski J; Bigalke G; Nitz RE Brux Med; 1974 May; 54(5):303-8. PubMed ID: 4214587 [No Abstract] [Full Text] [Related]
5. Methotrexate binding to dihydrofolate reductase. Roberts GC; Feeney J; Birdsall B; Charlton P; Young D Nature; 1980 Jul; 286(5770):309. PubMed ID: 7402318 [No Abstract] [Full Text] [Related]
6. Role of inhibitors in studies of comparative enzymology. Hitchings GH Fed Proc; 1967; 26(4):1078-81. PubMed ID: 6028773 [No Abstract] [Full Text] [Related]
7. Recent concepts on the mechanism of action of methotrexate. White JC Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663 [No Abstract] [Full Text] [Related]
9. Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan. Atkins HL; Christman DR; Fowler JS; Hauser W; Hoyte RM; Klopper JF; Lin SS; Wolf AP J Nucl Med; 1972 Oct; 13(10):713-9. PubMed ID: 5056684 [No Abstract] [Full Text] [Related]
10. Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate. Schlegel HB; Poe M; Hoogsteen K Mol Pharmacol; 1981 Jul; 20(1):154-8. PubMed ID: 7027022 [No Abstract] [Full Text] [Related]
11. Ultrastructural localization and distribution of free cholesterol (3-beta-hydroxysterols) in tissues. Williamson JR J Ultrastruct Res; 1969 Apr; 27(2):118-33. PubMed ID: 4890150 [No Abstract] [Full Text] [Related]
12. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line. Hamrell M; Laszlo J; Brown OE; Sedwick WD Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406 [No Abstract] [Full Text] [Related]
15. [Current topics in radiopharmaceuticals in Japan. (IV). Quality control of "Kit" made radiopharmaceuticals--radiochemical purity of 99mTc radiopharmaceuticals]. Yokoyama A Radioisotopes; 1984 Mar; 33(3):170-9. PubMed ID: 6382453 [No Abstract] [Full Text] [Related]
16. Determination of the rates of synthesis and degradation of enzymes by complex formation with radioactive ligands. Hanggi UJ FEBS Lett; 1976 Sep; 68(1):35-7. PubMed ID: 964378 [No Abstract] [Full Text] [Related]
17. Methotrexate. I. Pharmacology and pharmacokinetics. Lippens RJ Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629 [TBL] [Abstract][Full Text] [Related]
18. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates. Matherly LH; Anderson LA; Goldman ID Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765 [TBL] [Abstract][Full Text] [Related]
19. [The metabolism of drugs labelled with C14 and H3: from animal experimentation to use in man]. Glasson B; Benakis A Rev Eur Etud Clin Biol; 1971 Mar; 16(3):209-15. PubMed ID: 5555987 [No Abstract] [Full Text] [Related]
20. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. Chu BC; Fan CC; Howell SB J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]